Buffalo, NYNCT04683003Now EnrollingIRB Ready

Thrombotic Thrombocytopenic Purpura Clinical Trial in Buffalo, NY

Access cutting-edge thrombotic thrombocytopenic purpura treatment through this clinical trial at a research site in Buffalo. Study-provided care at no cost to qualified participants.

Sponsored by Takeda

Quick Self-Assessment

See if you qualify for this Buffalo location

Preparing your pre-screening questions...

Expert Care in Buffalo

Access thrombotic thrombocytopenic purpura specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related thrombotic thrombocytopenic purpura treatment provided free

Apply for This Buffalo Location

Check if you qualify for this thrombotic thrombocytopenic purpura clinical trial in Buffalo, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Buffalo

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Buffalo site if eligible
  4. 4Begin participation

About This Thrombotic Thrombocytopenic Purpura Study in Buffalo

Thrombotic thrombocytopenic purpura (or TTP for short) is a condition where blood clots form in small blood vessels throughout the body. The clots can limit or block the flow of oxygen-rich blood to the body's organs, such as the brain, kidneys, and heart. As a result, serious health problems can develop. The increased clotting that occurs in TTP uses up the cells that help the blood to clot, called platelets. With fewer platelets available in the blood, bleeding problems can also occur. People

Sponsor: Takeda

Who Can Participate

Inclusion Criteria

Participants who have completed TAK-755 Phase 3 pivotal Study 281102 (NCT03393975) in the prophylactic cohort and who meet all of the following criteria are eligible for this study:
Participants or legally authorized representative has provided signed informed consent \>=18 years of age and/or assent form \<18 years of age.
Participant 0 to 70 years of age at the time of screening of the 281102 (NCT03393975) study.
Participant has been diagnosed with severe congenital ADAMTS-13 deficiency.
Participant does not display any severe thrombotic thrombocytopenic purpura (TTP) signs (platelet count \<100,000/ microliter (mcL) and elevation of lactate dehydrogenase (LDH) greater than (\>) 2 × ULN at screening (prophylactic cohort only).
Participants \>=16 years of age must have a Karnofsky score \>= 70% and participants \<16 years of age must have a Lansky score \>=80%.
If female of childbearing potential, participant presents with a negative serum or urine pr

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Buffalo?

Yes, this clinical trial (NCT04683003) has an active research site in Buffalo, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Thrombotic Thrombocytopenic Purpura Treatment Options in Buffalo, NY

If you're searching for thrombotic thrombocytopenic purpura treatment options in Buffalo, NY, this clinical trial (NCT04683003) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Buffalo research site is actively enrolling participants for this clinical trial. You'll receive care from experienced thrombotic thrombocytopenic purpura specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all thrombotic thrombocytopenic purpura clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Buffalo, NY

See all pulmonary embolism clinical trials recruiting in Buffalo — not just this study.

Browse Pulmonary Embolism Trials in Buffalo

Ready to Join in Buffalo?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Buffalo, NY